Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 07, 2024 08:15 ET | Source: Trinity Biotech plc

Trinity Biotech Announces Positive Pre-Pivotal Trial Results for Its Next-Generation Continuous Glucose Monitor Technology

DUBLIN, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including...
September 24, 2024 16:05 ET | Source: Trinity Biotech plc

Trinity Biotech Announces Acquisition of Metabolomics Diagnostics to Grow Presence in Maternal Health Market

-Metabolomics Diagnostics, a deep-tech machine learning diagnostic platform developer, has developed an innovative test, PrePsia, to accurately predict the risk of preeclampsia in pregnant women- ...
September 18, 2024 16:05 ET | Source: Trinity Biotech plc

Trinity Biotech to Initiate CGM Market Study in India in Furtherance of Intended Collaboration with Bayer

DUBLIN, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including...
September 09, 2024 16:05 ET | Source: Trinity Biotech plc

Trinity Biotech Provides an Update on the Continued Development of Its Continuous Glucose Monitor Technology

DUBLIN, Ireland, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions,...
September 03, 2024 09:55 ET | Source: Trinity Biotech plc

Trinity Biotech Appoints Global Life Sciences Leader as Chief Commercial Officer

DUBLIN, Ireland, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions,...
August 26, 2024 16:05 ET | Source: Trinity Biotech plc

Trinity Biotech Announces Increased Orders for TrinScreen HIV and Raises Guidance For 2024 Sales

DUBLIN, Ireland, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions,...
August 20, 2024 17:00 ET | Source: Trinity Biotech plc

Trinity Biotech Appoints Diabetes Care Veteran as Biosensor Marketing Director

DUBLIN, Aug. 20, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including...
August 14, 2024 07:30 ET | Source: Trinity Biotech plc

Trinity Biotech Announces Q2 2024 Financial Results

-Q2, 2024 total revenues of $15.8 million grew +14% Y/Y and +7.7% Q/Q based on strong demand and output in the TrinScreen HIV business- -Point-of-Care product revenue of $4.6 million grew 119% Y/Y...
August 13, 2024 16:05 ET | Source: Trinity Biotech plc

Trinity Biotech to Announce Q2 2024 Financial Results

DUBLIN, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics,...
August 06, 2024 16:05 ET | Source: Trinity Biotech plc

Trinity Biotech Obtains an Extension to Demonstrate Compliance With Nasdaq Listing Requirements

DUBLIN, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions, including...